# AN2 Therapeutics, Inc.: funding, 10-K, NIH (November 2026)

Registers read on November 19, 2026.

AN2 Therapeutics, Inc. (California) appears in 3 public registers SpecStream reads: 1 Form D filing, 5 SEC annual and quarterly reports and 1 NIH or NSF award; the newest record is dated March 25, 2026, and the registers were read on November 19, 2026.

SpecStream is the live web data engine for teams and agents. This page joins the public registers SpecStream already reads for one company.

- Registers: 3
- Newest record: March 25, 2026
- State: California

## Form D filings (SEC)

1 Form D filing, newest March 25, 2026.

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Form D](https://specstream.ai/data/form-d/company/an2-therapeutics-inc-1880438) | March 25, 2026 | $40 million sold of $40 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1880438/000188043826000001/0001880438-26-000001-index.htm) |

- [AN2 Therapeutics, Inc.](https://specstream.ai/data/form-d/company/an2-therapeutics-inc-1880438)
- [SEC EDGAR filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1880438&type=D)

## Public company financials (SEC)

5 SEC annual and quarterly reports, newest March 17, 2026.

- SEC central index key (CIK): 1880438
- Industry: SIC 2834, Pharmaceutical preparations
- Filer category: Non-accelerated filer

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [10-K filed March 17, 2026](https://specstream.ai/data/public-companies/company/1880438-an2-therapeutics-inc) | March 17, 2026 | SIC 2834, Pharmaceutical preparations | [sec.gov](https://www.sec.gov/Archives/edgar/data/1880438/000119312526110693/0001193125-26-110693-index.htm) |

- [AN2 Therapeutics, Inc.](https://specstream.ai/data/public-companies/company/1880438-an2-therapeutics-inc)

## NIH and NSF research awards

1 NIH or NSF award, newest September 20, 2022.

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [NIH](https://specstream.ai/data/research-funding/organization/an2-therapeutics-inc-dd4fe2ge4l78) | September 20, 2022 | Development of a Novel Therapeutic for Melioidosis; $9.2 million | [reporter.nih.gov](https://reporter.nih.gov/project-details/11326615) |

- [An2 Therapeutics, Inc.](https://specstream.ai/data/research-funding/organization/an2-therapeutics-inc-dd4fe2ge4l78)

## How these records were matched

Records are joined when they carry the same SEC CIK, EIN or UEI, or when their legal names match word for word, legal form aside, at an address in the same state (California), and no register gives a second identifier, a second headquarters or a second filer of that name. Each record links to its own page and to the agency that published it.

Source: the registers named in each section. Public records of US federal and state agencies.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in California

- [Pharmaceutical companies in California, United States](https://specstream.ai/data/businesses/pharmaceutical-companies/california-united-states)
- [Pipe suppliers in California, United States](https://specstream.ai/data/businesses/pipe-suppliers/california-united-states)
- [Pediatric dentistry practices in California, United States](https://specstream.ai/data/businesses/pediatric-dentistry-practices/california-united-states)
- [Packing services in California, United States](https://specstream.ai/data/businesses/packing-services/california-united-states)
- [Oncology practices in California, United States](https://specstream.ai/data/businesses/oncology-practices/california-united-states)
- [Naturopathic clinics in California, United States](https://specstream.ai/data/businesses/naturopathic-clinics/california-united-states)
